Dennis J. Wright
Chief Tech/Sci/R&D Officer bij CLINUVEL PHARMACEUTICALS LIMITED
Vermogen: 1 M $ op 31-03-2024
Profiel
Dennis J.
Wright is currently the Chief Scientific Officer at Clinuvel Pharmaceuticals Ltd.
He previously worked as the Manager-Global Pharmacovigilance at Mayne Pharma Ltd.
Dr. Wright completed his undergraduate and graduate degrees at The University of Sydney.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-08-2023 | 156 874 ( 0.31% ) | 1 M $ | 31-03-2024 |
Actieve functies van Dennis J. Wright
| Bedrijven | Functie | Begin |
|---|---|---|
| CLINUVEL PHARMACEUTICALS LIMITED | Chief Tech/Sci/R&D Officer | - |
Eerdere bekende functies van Dennis J. Wright
| Bedrijven | Functie | Einde |
|---|---|---|
Mayne Pharma Ltd.
 Mayne Pharma Ltd. Pharmaceuticals: OtherHealth Technology Mayne Pharma Ltd. manufactures pharmaceutical products. It distributes generic injectables for the oncology market. The company's competitors include Sandoz, Bedford Labs, and Ebewe. It was founded in November 2005 and is headquartered in Melbourne, Australia. | General Counsel | - |
Opleiding van Dennis J. Wright
| The University of Sydney | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
| Clinuvel Pharmaceuticals Ltd. | |
Mayne Pharma Ltd.
Mayne Pharma Ltd. Pharmaceuticals: OtherHealth Technology Mayne Pharma Ltd. manufactures pharmaceutical products. It distributes generic injectables for the oncology market. The company's competitors include Sandoz, Bedford Labs, and Ebewe. It was founded in November 2005 and is headquartered in Melbourne, Australia. | Health Technology |
